CSIMarket
 
Neos Therapeutics Inc   (NASDAQ: NEOS)
 

Neos Therapeutics Inc's Customers Performance

NEOS



 
NEOS's Source of Revenues During the corresponding time, Neos Therapeutics Inc recorded a revenue increase by 86.75 % year on year, sequentially revenue grew by 10.03 %. While revenue at the Neos Therapeutics Inc 's corporate clients

List of NEOS Customers




for the same period Neos Therapeutics Inc recorded revenue increase by 86.75 % year on year, sequentially revenue grew by 10.03 %.

List of NEOS Customers

Neos Therapeutics Inc's Business Units






Neos Therapeutics Inc's Comment on Sales, Marketing and Customers
















NEOS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Neos Therapeutics Inc 57.22 42.38 -56.56 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Neos Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Neos Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Neos Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.